NCNA

NuCana plc NCNA

NasdaqLarge CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-29.35M

Quarter to Dec 31

Free cash flow

$-7.47M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$168.2K total
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NCNA

Loading ratio trend…

NCNA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About NuCana plc (NCNA): stock profile, AI score and financials

NuCana plc (NCNA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NCNA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), NuCana plc reports net income of $-29.4M, free cash flow of $-7.5M. Top institutional holders of NCNA by reported 13-F value include StoneX Group, CITADEL ADVISORS, HRT FINANCIAL, based on the most recent SEC filings. NCNA trades on the Nasdaq exchange and files with the SEC under CIK 1709626. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NCNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NuCana plc directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1709626 →